Valion Bio
VBIO
2 hedge funds and large institutions have $54 invested in Valion Bio in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.16% less ownership
Funds ownership: 0.17% → 0% (-0.16%)
78% less funds holding
Funds holding: 9 → 2 (-7)
100% less capital invested
Capital invested by funds: $90.7K → $54 (-$90.6K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$19K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$19K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$16.3K |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$13.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$12.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SS
1
SBI Securities
Tokyo,
Japan
| $41 | -$10 | -2 | -11% |
|
|
2
Bank of America
Charlotte,
North Carolina
| $13 | +$5 | +1 | +25% |
|
|
HF
3
HRT Financial
New York
| – | -$19K | -3,450 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$19K | -3,224 | Closed |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| – | -$16.3K | -2,822 | Closed |
|
|
GSC
6
Ground Swell Capital
Folly Beach,
South Carolina
| – | -$13.1K | -2,269 | Closed |
|
|
7
Geode Capital Management
Boston,
Massachusetts
| – | -$12.4K | -2,145 | Closed |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | -$6.53K | -1,111 | Closed |
|
9
Two Sigma Investments
New York
| – | -$4.21K | -715 | Closed |
|
VBIO Hedge Fund Activity: Q1 2025 in Review
2 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Valion Bio (VBIO) for Q1 2025, worth a combined $54 — down 100% from $90.7K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of VBIO and 0 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Bank of America, adding an estimated $5. The largest seller was HRT Financial, exiting entirely with an estimated $19K sold.
- 2 institutional investors held Valion Bio (VBIO) as of Q1 2025, down from 9 in Q4 2024.
- Funds reported $54 of Valion Bio stock for Q1 2025, down 100% quarter-over-quarter.
- 0 funds opened new Valion Bio positions in Q1 2025 and 7 closed out, a net change of -7 holders.
- The largest Valion Bio buyer in Q1 2025 was Bank of America, an estimated $5 added.
- The largest Valion Bio seller in Q1 2025 was HRT Financial, an estimated $19K sold.
Based on aggregated 13F filings for Q1 2025.